STEPHANY LAVIGNE: Open Payments
NPI 1669065660 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 9 payments from 5 companies in 2025. Trend: 2023 $1,202 · 2024 $960 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $60 |
| Lundbeck LLC | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| ABBVIE INC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: REXULTI, Auvelity, CAPLYTA, VRAYLAR.
Industry payments across CA — which companies pay providers there.
